The adaptive treatment tolerance (ATT) of cancer cells is the main encumbrance to cancer
chemotherapy. A potential solution to this problem is to treat cancer cells with multiple drugs …

Abstract Plumbagin (5-hydroxy-2-methyl-1, 4-naphthoquinone) is a naturally occurring
phytochemical, mainly found in the roots of the Plumbago zeylanica L. Plumbagin (PLB) …

Site-specific delivery of drugs while minimizing unwanted distribution has been one of the
pursued goals in cancer therapy. In this endeavor, we have developed targeted polymeric …

Self-assembled nanostructures based on amphiphilic protein–polymer conjugates have
shown great advantages in the field of nanomedicine such as inherent biocompatibility with …

Resistance to common chemotherapeutic agents is a frequent phenomenon in late-stage
breast cancers. An ideal system capable of the co-delivery of hydrophobic and hydrophilic …

Development of drug carriers, which can chaperone xenobiotics directly to their site of
action, is an essential step for the advancement of precision medicine. Cationic …

The synergistic combination of photothermal and RNA interference therapy demonstrates
great potential for effective treatment of metastatic breast cancer, but their efficacy is limited …

Proanthocyanidins (PACs), a group of polyphenolic secondary metabolites in plants, have
drawn great interest because of their enormous potential in reducing the incidence of …

Tetrahydrocurcumin (THC) is a natural molecule with anticancerous, antioxidant and other
beneficial activities. However, its low aqueous solubility leads to poor bioavailability. Sodium …

Nanotechnology-based drug delivery research has largely focused on developing well
efficient localized delivery therapeutic agents to overcome the limitations of non-specificity …